ABUS EBITDA Growth
Arbutus Biopharma Corp · EBITDA Growth
ABUS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported372.10%period ending
ABUS TTM EBITDA YoY % (-124.06% → 372.10%)
Year-over-year change
High-resolution chart · PNG
ABUS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 372.1013% | |
| 305.5302% | |
| 53.8334% | |
| 41.5551% | |
| 26.6369% | |
| -5.8912% | |
| 0.9261% | |
| -5.0493% | |
| -9.8856% | |
| -11.0131% | |
| -18.0572% | |
| -19.7698% | |
| -12.8586% | |
| -0.7826% | |
| 13.5028% | |
| 8.3542% | |
| 5.5316% | |
| -9.2391% | |
| -22.629% | |
| -21.1779% | |
| 50.0168% | |
| 57.2211% | |
| 61.9898% | |
| 65.1114% | |
| -43.3356% | |
| -61.5545% | |
| -86.2377% | |
| -26.9713% | |
| 13.8345% | |
| 16.6026% | |
| 23.4431% | |
| -87.0826% | |
| -42.7071% | |
| -39.3117% | |
| -46.3826% | |
| -12.7647% | |
| -38.9749% | |
| -54.5285% | |
| -74.5068% | |
| -23.345% | |
| -34.2502% | |
| -38.4152% | |
| -28.4406% | |
| -96.7007% | |
| -90.6075% | |
| -141.98% | |
| -180.7754% | |
| -60.7658% | |
| -59.8327% | |
| -16.6153% | |
| 4.1032% | |
| -75.059% | |
| -56.436% | |
| -30.8169% | |
| -19.7932% | |
| 44.6537% | |
| 48.5952% | |
| 40.8087% | |
| 41.1948% | |
| -35.7867% | |
| -46.2895% | |
| -74.6762% | |
| -156.4566% | |
| -162.7565% | |
| -138.2864% | |
| -14.2127% | |
| 10.2518% | |
| 65.8576% | |
| 46.6817% | |
| -124.0582% |